======= TNFRSF6B =======
== Gene Information ==
* **Official Symbol**: TNFRSF6B
* **Official Name**: TNF receptor superfamily member 6b
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=8771|8771]]
* **UniProt**: [[https://www.uniprot.org/uniprot/O95407|O95407]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=TNFRSF6B&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20TNFRSF6B|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/603361|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: This gene belongs to the tumor necrosis factor receptor superfamily. The encoded protein is postulated to play a regulatory role in suppressing FasL- and LIGHT-mediated cell death. It acts as a decoy receptor that competes with death receptors for ligand binding. Over-expression of this gene has been noted in gastrointestinal tract tumors. Read-through transcription into this gene from the neighboring upstream gene, which encodes regulator of telomere elongation helicase 1 (RTEL1), generates a non-coding transcript. [provided by RefSeq, Feb 2011].
* **UniProt Summary**: Decoy receptor that can neutralize the cytotoxic ligands TNFS14/LIGHT, TNFSF15 and TNFSF6/FASL. Protects against apoptosis. {ECO:0000269|PubMed:21300286}.
No Pfam Domain information is available for this gene.
|tumor necrosis factor-mediated signaling pathway|
|signaling receptor activity|
|cellular response to tumor necrosis factor|
|response to tumor necrosis factor|
|cytokine-mediated signaling pathway|
|negative regulation of apoptotic process|
|negative regulation of programmed cell death|
|apoptotic process|
|negative regulation of cell death|
|cellular response to cytokine stimulus|
|programmed cell death|
|cell death|
|response to cytokine|
|regulation of apoptotic process|
|regulation of programmed cell death|
|extracellular space|
|regulation of cell death|
|extracellular region|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp262|Alda-1 10μM R06 exp262]]|-2.02|
|[[:results:exp239|PFI-2 4μM R05 exp239]]|-1.72|
|[[:results:exp136|MS094 2μM R03 exp136]]|-1.71|
|[[:results:exp48|Mubritinib 0.2μM R01 exp48]]|1.7|
|[[:results:exp51|Nifuroxazide 1μM R01 exp51]]|1.71|
|[[:results:exp49|NFN1 0.1μM R01 exp49]]|1.8|
|[[:results:exp46|HMS-I1 1μM R01 exp46]]|1.9|
|[[:results:exp42|BI-6727 0.001μM R01 exp42]]|2.11|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 0/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 4403
* **Expression level (log2 read counts)**: -1.62
{{:chemogenomics:nalm6 dist.png?nolink |}}